AARDEX Group

Company News

The Contract Pharma October Issue is now live which includes an article about AARDEX Group

Medication adherence, which involves patients taking medications in accordance with how they have been prescribed, is a widespread challenge, with wide-reaching implications for patients and health services worldwide. Managing patient compliance can make the difference between failed and successful clinical … Read More

AARDEX announces the world’s first DIGITAL MEDICATION ADHERENCE MONITORING solution fully integrated in the clinical trial platform by a top 10 pharma company.

AARDEX is proud to announce the integration of its MEMS® Adherence Software by a major pharmaceutical company. It’s the first end-to-end integration of electronically compiled dosing histories using smart packages from interactive response technology (IRT) into electronical data capture systems … Read More

How digital medication adherence monitoring increases the impact of innovative adherence research?

MEMS® has been a part of successful adherence research for more than 30 years.Download this adherence compendium and find out how digital medication adherence monitoring increases the impact of academic research findings.

Aardex Pharma Video

This video shows how to speed up your drug development.

Discover why the Pharmaceutical world trusts us to resolve patient non-compliance. … Read More

blog-image

AARDEX leading position in the B2B medication adherence market

AARDEX still confirms its leading position in the B2B medication adherence market … Read More

writer_img

AARDEX Group announces successful management buyout

FEB-2018 : The Belgian-Swiss company AARDEX Group has announced the completion … Read More

Clinical-and-research

Clinical and research excellence awards 2016

Best Patient-Focused Technological Development at the First Clinical and Research Excellence … Read More